
Azido-PEG6-t-butyl ester | CAS 406213-76-1
| Catalog Number | R14-0240 |
| Category | Azides |
| Molecular Formula | C19H37N3O8 |
| Molecular Weight | 435.51 |
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Product Introduction
Azido-PEG6-C2-Boc is a polyethylene glycol (PEG)-based PROTAC linker. Azido-PEG6-C2-Boc can be used in the synthesis of a series of PROTACs.
Chemical Information
Product Specification
Computed Properties
Patents
| Synonyms | N3-PEG6-CH2CH2COOtBu; 2-Methyl-2-propanyl 1-azido-3,6,9,12,15,18-hexaoxahenicosan-21-oate; N3-PEG6-tBu; Azido-PEG6-C2-Boc; tert-butyl 1-azido-3,6,9,12,15,18-hexaoxahenicosan-21-oate; Azido-PEG6-Boc; 3,6,9,12,15,18-Hexaoxaheneicosan-21-oic acid, 1-azido-, 1,1-dimethylethyl ester; 21-Azido-4,7,10,13,16,19-hexaoxaheneicosanoic acid 1,1-dimethylethyl ester |
| Purity | >97% |
| IUPAC Name | tert-butyl 3-[2-[2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate |
| Canonical SMILES | CC(C)(C)OC(=O)CCOCCOCCOCCOCCOCCOCCN=[N+]=[N-] |
| InChI | InChI=1S/C19H37N3O8/c1-19(2,3)30-18(23)4-6-24-8-10-26-12-14-28-16-17-29-15-13-27-11-9-25-7-5-21-22-20/h4-17H2,1-3H3 |
| InChIKey | HRNUWAOLFSWRDG-UHFFFAOYSA-N |
| Solubility | Soluble in DMSO |
| Appearance | Colorless Liquid |
| Storage | Store at 2-8°C for short term (days to weeks) or -20°C for long term (months to years) |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 23 |
| Exact Mass | 435.25806515 g/mol |
| Monoisotopic Mass | 435.25806515 g/mol |
| Topological Polar Surface Area | 96Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 454 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
| Publication Number | Title | Priority Date |
|---|---|---|
| US-2018161446-A1 | Antibody drug conjugate, intermediate, preparation method, pharmaceutical composition and uses thereof | 2015-06-09 |
| EP-2917195-B9 | Spliceostatin analogs | 2012-11-05 |
| US-2014134193-A1 | Spliceostatin analogs and methods for their preparation | 2012-11-05 |
| US-2016022626-A1 | Spliceostatin analogs and methods for their preparation | 2012-11-05 |
| US-2017014523-A1 | Spliceostatin analogs and methos for their preparation | 2012-11-05 |
Recommended Services
Recommended Articles
- Hoechst Dyes: Definition, Structure, Mechanism and Applications
- Mastering the Spectrum: A Comprehensive Guide to Cy3 and Cy5 Dyes
- Fluorescent Probes: Definition, Structure, Types and Application
- Fluorescent Dyes: Definition, Mechanism, Types and Application
- Coumarin Dyes: Definition, Structure, Benefits, Synthesis and Uses
- BODIPY Dyes: Definition, Structure, Synthesis and Uses
- Cyanine Dyes: Definition, Structure, Types and Uses
- Fluorescein Dyes: Definition, Structure, Synthesis and Uses
- Rhodamine Dyes: Definition, Structure, Uses, Excitation and Emission
- Unlocking the Power of Fluorescence Imaging: A Comprehensive Guide
- Cell Imaging: Definitions, Systems, Protocols, Dyes, and Applications
- Lipid Staining: Definition, Principles, Methods, Dyes, and Uses
- Flow Cytometry: Definition, Principles, Protocols, Dyes, and Uses
- Nucleic Acid Staining: Definition, Principles, Dyes, Procedures, and Uses
- DNA Staining: Definition, Procedures, Benefits, Dyes and Uses
- Cell Staining: Definition, Principles, Protocols, Dyes, and Uses
- Ion Imaging: Definition, Principles, Benefits, Dyes, and Uses
- Fluorescent Labeling: Definition, Principles, Types and Applications
Recommended Products
Online Inquiry